Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
21.51
+0.91 (4.42%)
Apr 1, 2025, 2:45 PM CST
SHA:600079 Revenue
Humanwell Healthcare (Group) had revenue of 6.28B CNY in the quarter ending September 30, 2024, with 9.66% growth. This brings the company's revenue in the last twelve months to 25.56B, up 5.63% year-over-year. In the year 2023, Humanwell Healthcare (Group) had annual revenue of 24.52B with 9.79% growth.
Revenue (ttm)
25.56B
Revenue Growth
+5.63%
P/S Ratio
1.30
Revenue / Employee
1.45M
Employees
17,676
Market Cap
33.14B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 24.52B | 2.19B | 9.79% |
Dec 31, 2022 | 22.34B | 1.79B | 8.71% |
Dec 31, 2021 | 20.55B | -131.18M | -0.63% |
Dec 31, 2020 | 20.68B | -1.13B | -5.17% |
Dec 31, 2019 | 21.81B | 3.17B | 17.03% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 26.00B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |